HEALTH OF WOMAN.2015.10(106):51–55 

Evaluation of potential preventive drug Canephron® N in treatment of recurrent cystitis in women of reproductive age 

Shulyak A. V., Sabadash N. E.

SI «Institute of urology of National Academy of medical Sciences of Ukraine», Kyiv 

In the article the data open, mono center, prospective study, conducted at the Institute of Urology control NAMS Ukraine which participated 60 patients with recurrent cystitis in exacerbation caused by Escherichia coli, which were divided into groups and comparing the basic. The main group besides antibacterial drug took Phitopreparation Canephron® N for 3 months after basic treatment. The results show that taking Canephron® N reduces the number of positive bacteriological urine 7 days after receiving a / b, and 20% reduces the number of recurrences after 12 months of follow – 16.67% and 36.67% p <0.05 in and control group, respectively, without causing any adverse reactions. 

Key words: chronic and recurrent cystitis, Сanephron® H, treatment. 

REFERENCES

1. Иванов ДД, Кушниренко СВ. 2014. Острый цистит у детей. Лечебный и профилактический потенциал фитотерапии. Здоров’я України 3.

2. Иванов ДД, Назаренко ВИ, Кушниренко СВ и соавт. 2005. Фитотерапия метаболического синдрома и сахарного диабета 2 типа: возможности фитониринга. Здоров’я Украiни 17:46–47.

3. Урология. Национальное руководство. Под ред. НА Лопаткина. М, ГЭОТАР-Медиа. 2009:1024.

4. Abdul-Ghani AS, El-Lati SG, Sacaan A et al. 1987. Anticonvulsant effects of some Arab medicinal plants. Int J Crude Drug Res 25:39–43. http://dx.doi.org/10.3109/13880208709060909

5. Barbosa-Cesnik C, Brown MB, Buxton M et al. 2011, Jan. Cranberry juice fail stop revent recurrent urinary tract infection: results from a randomised placebo-controlled trial. ClinInfectDis 52(1):23–30.

6. Bauer HW, Rahlfs VW, Lauener PA et al. 2002, Jun. Prevention of recurrent urinary tract infections with immunoactive E. сoli fractions: a meta-analysisoffive placebo-controlled double-blind studies. Int J AntimicrobAgents 19(6):451–6.

7. Boscia JA, Kaye D. 1987. A symptomatic bacteriuriain theelderly. Infect. Dis. Clin. North Am. 1:893–905.

8. European Scientific Cooperative on Phytotherapy. Centaurii herba (Centaury herb). In: ESCOP Monographs. 2nd ed. Stuttgart, Germany, and New York: Thieme-Verlag. 2003:70–73.

9. European Scientific Cooperative on Phytotherapy. Rosmarini folium (Rosemary leaves). In: ESCOP Monographs. 2nd ed. Stuttgart, Germany, and New York: Thieme-Verlag; 2003:429–436.

10. Gracza L, Koch H, Loffler E. 1985. Isolierung von Rosmarinsaure aus Symphytum officinale und ihre antiinflammatorische Wirksamkeit in einem In-vitro.Modell. Arch Pharm 318:1090–1095. http://dx.doi.org/10.1002/ardp.19853181207

11. Greenberg А. 1990. History of Genitourinary Disease.

12. Haloui M, Louedec L, Michel B, Lyoussi B. 2000. Experimental diuretic effects of Rosmarinus officinalis and Centaurium erythraea. J Ethnopharmacol 71:465–472. http://dx.doi.org/10.1016/S0378-8741(00)00184-7

13. Johnson JR. 1991. Virulence factors in urinary tract infection. ClinMicrobiolRev 4:80–128.

14. Kontiokari T, Sundqvist K, Nuutinen M et al. 2001, Jun. Randomised trial of cranberry-lingonberry juice and Lactobacillus GG drink for the prevention of urinary tract infections in women. BMJ 322(7302):1571.

15. Kumarasamy Y, Nahar L, Cox PJ et al. 2003. Bioactivity of secoiridoid glycosides from Centaurium erythraea. Phyto-medicine 10:344–347. http://dx.doi.org/10.1078/094471103322004857; PMid:12809366

16. Kumarasamy Y, Nahar L, Sarker SD. 2003. Bioactivity of gentiopicroside from the aerial parts of Centaurium erythraea. Fitoterapia 74:151–154. http://dx.doi.org/10.1016/S0367-326X(02)00319-2

17. Naber KG, Cho YH, Matsumoto T et al. 2009, Feb. Immunoactive prophylaxis of recurrent urinary tract infections:a meta-analysis. Int J Antimicro-bAgents 33(2):111–9.

18. Naboka IL, Kogan MI, Vasil’eva LI, Gudima IA, Miroshnichenko EA, and Ibishev KS. 2011. Bacterial mixed infection in women with chronic recurrent cystitis. Zhurnal Mikrobiologii, Epidemiologii, i Immunobiologii. 1:8–12.

20. Nickel JC, Shoskes DA, and Irvine-Bird K. 2010. Prevalence an dimpact of bacteriuria and / or urinary tract infection in interstitial cystitis / painful bladder syndrome. Urology, 76;4:799–803. http://dx.doi.org/10.1016/j.urology.2010.03.065; PMid:20573386

21. Rampart M, Beetjens JR, Bult H et al. 1986. Complementdependent stimulation of prostacyclin biosynthesis; inhibition by rosmarinic acid. Biochem Pharmacol 35:1397–1400. http://dx.doi.org/10.1016/0006-2952(86)90289-3

22. Raz R. 1993. A controlledtrial of intravaginal estriolin postmenopausal women with recurrent urinary tract infections. R. Raz, WE. Stamm: N Engl J Med 329:753–756

23. Stanfordand E, McMurphy С. 2007. Thereis a low incidence of recurrent bacteriuriain painful bladder syndrome /interstitial cystitis patients followed longitudinally. International Urogyne cology Journal and PelvicFloorDysfunction 18;5:551–554. http://dx.doi.org/10.1007/s00192-006-0184-9; PMid:17036170

24. Stothers L. 2002, Jun. A randomized trial to evaluate effective ness and cost effective ness of naturopathic cranberry products as prophylaxis against urinary trac tinfection in women. Can J Urol 9(3):1558–62.

25. Valentao P, Fernandes E, Carvalho F et al. 2003. Hydroxyl radical and hypochlorous acid scavenging activity of small centaury (Centaurium erythraea) infusion. A comparative study with green tea (Camellia sinensis). Phyto-medicine 10:517–522).

26. Yamahara J, Konoshima I, Sawada I, Fujimura H. 1978. Biologically active principles of crude drugs: pharmacological actions of Swertia japonica extracts, swertiamarine and gentianine. Yakugaku Zasshi 98:1446–1451.

27. Yarnell E. 2002. Botanical medicines or the urinary tract. World J Urol 20:285–293.